Ordaos
Human-enabled, machine-driven drug design
- Employees
- 11–50
- Business Model
- B2B
- Website
- ordaos.bio
- Last Round
- Venture RoundJul 2025
- Rounds
- 2
About
Ordaōs is a human-enabled, machine-driven drug design company that uses generative AI to create novel mini-proteins (miniPRO) for targeted drug therapies. The company's proprietary AI engine designs bespoke mini-proteins to help drug hunters deliver treatments that reduce patient suffering and cure without harm. Ordaōs focuses on overlooked patient populations and diseases underserved by traditional drug discovery. Backed by Johnson & Johnson Innovation (JLABS).
Summary
Ordaos is an Artificial Intelligence company. Its most recent funding was a Venture Round round in Jul 2025. Investors include Route 66 Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...